You can make huge gains investing in a breakthrough drug, but you
can do even better putting your money into a new, cutting-edge
technology platform that can fuel a company's entire pipeline.
One biotech I recommended to my BioScience Millionaire subscribers last July, Sangamo Biosciences Inc. (Nasdaq: SGMO), has developed a technology from naturally occurring molecules, called zinc finger proteins (ZFPs),
that scientists can engineer to edit specific genes in the human
genome. It can cut them out, replace them, or add new ones - in other
words, it plays with the basic building blocks of life as if they were
Lego pieces!
Sangamo is currently using ZFP technology to find cures for some of
the most intractable - and often un-druggable - diseases we know of,
including HIV, Alzheimer's, Huntington's, and Down's syndrome to name a
few. (more)
Please share this article
No comments:
Post a Comment